Predominantly hemorrhagic choroidal neovascular lesion from exsudative age-related macular degeneration treated with intravitreal ranibizumab therapy

Revista Brasileira de Oftalmologia

Miguel Hage Amaro²  Aaron Brock Holler¹ 

[1] ,Private PracticeBelém PA ,Brazil

关键词: Macular degeneration;    Choroidal neovascularization;    Angiogenesis inhibitors;    Antibodies monoclonal;    Case reports;    Degeneração macular;    Neovascularização coroidal;    Inibidores da angiogênese;    Anticorpos monoclonais;    Relato de casos;   

DOI  :  10.1590/S0034-72802013000300009

来源: SciELO

【 摘 要 】

The authors relate a predominantly hemorrhagic choroidal neovascular lesion from neovascular. Age-related macular degeneration patient case treated with intravitreal ranibizumab therapy. Monthly ranibizumab (six intravitreal injections) displayed a promising response but this limited report is insufficient to guarantee the indication for all predominantly hemorrhagic choroidal neovascular lesion from neovascular age-related macular degeneration. Further studies will be necessary for complete validation of our results for all predominantly hemorrhagic choroidal neovascular lesions from CNV due to AMD.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License